Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
McKesson
Medtronic
Dow
Moodys

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Human Genome Sciences Inc. v. Immunex Corp. (D. Del. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Human Genome Sciences Inc. v. Immunex Corp. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-11-30
Court District Court, D. Delaware Date Terminated 2008-05-12
Cause 35:0146 Review of Board of Patent Appeals Decision Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties AMGEN INC.; HUMAN GENOME SCIENCES INC.; IMMUNEX CORP.
Patents 4,179,337; 5,464,764; 5,821,047
Attorneys Chad S.C. Stover; John G. Day; Lois Kwasigroch; Melanie K. Sharp; Wendy A. Whiteford
Firms Barnes and Thornburg LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Human Genome Sciences Inc. v. Immunex Corp.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Human Genome Sciences Inc. v. Immunex Corp.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Human Genome Sciences Inc. v. Immunex Corp. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-11-30 1 Complaint or decreased immunogenicity (see U.S. Pat. No. 4,179,337). The chemical moieties for deriv- itization may… States Patent Ni et al. Filed 11/30/2007 Page 2 Of 98 (10) Patent No.: (45) Date of Patent: Us 6,872,568… the Board of Patent Appeals and Interferences (the “Board”) of the United States Patent and Trademark…invention disclosed in U.S. Patent 6,872,568, issued March 29, 2005 (“the ’5 68 patent”), entitled “Death domain…0042 UNITED STATES PATENT AND TRADEMARK OFFICE BEI-`ORE TH_E BOARD OF PATENT APPEALS AND INTERFERENCES External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Boehringer Ingelheim
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.